For the year ending 2025-12-31, AIRS had $214K increase in cash & cash equivalents over the period. $692K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -11,667 |
| Depreciation and amortization | 12,781 |
| Equity-based compensation | 2,331 |
| Non-cash interest expense amortization of debt costs | 525 |
| Deferred income taxes | -5,914 |
| Loss on impairment of long-lived assets | 4,575 |
| Cost related to closing location | -2,152 |
| Taxes receivable | -1,556 |
| Prepaid expense and other current assets | 4,440 |
| Other assets | -6,669 |
| Accounts payable | 579 |
| Deferred revenue and patient deposits | 735 |
| Accrued and other liabilities | -6,786 |
| Net cash used in operating activities | 3,096 |
| Purchases of property and equipment, net | 2,404 |
| Net cash used in investing activities | -2,404 |
| Payments on term loan | 13,793 |
| Payments for debt modification | 393 |
| Payments on revolving credit facility | -5,000 |
| Proceeds from public offerings, net | 18,764 |
| Distribution to member | 0 |
| Dividends paid to shareholders | 0 |
| Payment of taxes withheld through vested equity-based compensation | 56 |
| Other financing activity | 0 |
| Net cash used in financing activities | -478 |
| Net decrease in cash and cash equivalents | 214 |
| Beginning of period | 8,235 |
| End of period | 8,449 |
Airsculpt Technologies, Inc. (AIRS)
Airsculpt Technologies, Inc. (AIRS)